Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ DRI™ Cotinine Drugs of Abuse Controls

Catalog No. 23278322
Change view
Click to view available options
Concentration:
300 ng/mL
700 ng/mL
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Concentration
23-278-322 300 ng/mL
21-200-415 700 ng/mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 23-278-322 Supplier Thermo Scientific™ Supplier No. 0460
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Reduce time-consuming reagent preparation with Thermo Scientific™ DRI™ Cotinine Drugs of Abuse Controls—ready-to-use controls in lilquid form.

Reduce time-consuming reagent preparation with Thermo Scientific™ DRI™ Cotinine Drugs of Abuse Controls—ready-to-use controls in lilquid form. Delivering high analytical accuracy, these assays have been field-tested on a wide range of analyzers. They are enthusiastically accepted in laboratories where cost control and optimal productivity are key issues.

  • Qualitative or semi-quantitative options for results
  • Excellent correlation to GC/MS
  • Applications for an array of clinical chemistry analyzers
  • Variety of calibrators and multiconstituent control sets
TRUSTED_SUSTAINABILITY

Specifications

Description DRI Cotinine Drugs of Abuse Controls
Concentration 300 ng/mL
Detectable Analytes Creatinine
Sample Type Urine
Type Control
Quantity 1 x 5 mL
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.